The EAA treatment markedly reduced acute gastritis symptoms (Fig. 6B and 6C) and prevented inflammatory responses by suppressing TNF-α secretion and nitrite overproduction (Fig. 6D and 6E). This evidence concerns the gene TNF and gastritis.